FDA Inspection 1067044 — Lonza Walkersville, Inc.
The FDA completed an inspection of Lonza Walkersville, Inc. on Jul 26, 2018 in Walkersville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Walkersville, MD (United States)